Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

42.16 -1.42 (-3.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quidelortho Corp

< Previous 1 2 3 4 5 6 7 Next >
Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm. 
Via Benzinga
Analyst Expectations for QuidelOrtho's Future
Via Benzinga
Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: Analyst
QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,  
Via Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
Where QuidelOrtho Stands With Analysts
Via Benzinga
QuidelOrtho's Return on Invested Capital Overview
Via Benzinga
QuidelOrtho: Q1 Earnings Insights
Via Benzinga
Why QuidelOrtho Stock Popped by 5% on Friday
It looks like the company's first quarter is going to please investors greatly. 
Via The Motley Fool
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
Analyst Says QuidelOrtho's Interim Earnings Update Should 'Ease Some Investor Fears'
Via Benzinga
Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why
Raymond James analyst Andrew Cooper reiterates Strong Buy on QuidelOrtho Corporation (NASDAQ: QDEL),  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets
Something Happened In Biotech Last Week
Biotech stocks were more constructive last week with some sharp moves up. 
Via Talk Markets
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro... 
Via Talk Markets
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why QuidelOrtho Stock Is Rising After Hours
QuidelOrtho Corp (NASDAQ: QDEL) shares are rising in extended trading Thursday after the company reported preliminary revenue results for  
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
4 Analysts Have This to Say About QuidelOrtho
Via Benzinga
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday. 
Via Benzinga
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Billionaire David Rubenstein Is Betting Big on ZoomInfo (ZI) Stock
ZoomInfo Technologies is billionaire David Rubenstein's top holding. Here's why he may be right to bet on ZI stock now. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.